As MORC2 is predominately localized in the nuclear (Figure 1E) [7], we hypothesized that the involvement of MORC2-CTNND1 interaction in breast cancer progression is mainly mediated by nuclear CTNND1. Here, CTNND1 is linked to breast carcinoma.